| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |